Literature DB >> 11500295

Methods for measuring glycogen cycling.

B R Landau1.   

Abstract

Simultaneous synthesis and breakdown of glycogen is called glycogen cycling. The extent of hyperglycemia and decreased glycogen stores in diabetes mellitus may relate in part to the extent cycling occurs. Four methods have been introduced to estimate its extent in liver in humans. 1) In the fasted state, the rate of net hepatic glycogenolysis, i.e., glycogen breakdown minus synthesis, is estimated using NMR, and the rate of glycogenolysis is estimated from deuterium labeling of blood glucose on (2)H(2)O ingestion. 2) The rate of glycogen synthesis is estimated from the rate of labeling of carbon 1 of glycogen on [1-(13)C]glucose infusion, monitored by NMR, and the rate of breakdown from the rate of disappearance of that labeling on unlabeled glucose infusion. 3) The rate of synthesis from glucose-1-P, formed by glycogenolysis, is measured by the decrease in the (3)H/(14)C ratio in acetaminophen glucuronide on acetaminophen and [2-(3)H,6-(14)C]galactose administration. 4) The rate of synthesis is estimated from the dilution of label from labeled galactose in its conversion to the acetaminophen glucuronide, and the rate of glycogenolysis is estimated from the amount of label in blood glucose. In the first method, the fate of glucose-6-P is assumed to be only to glycogen and glucose. In the second, only glucose-6-P molecules formed by breakdown that are not cycled back to glycogen are measured. In the third, (3)H is assumed to be removed completely during cycling, and only the molecules cycled back to glycogen are measured. In the fourth, galactose conversion to glucose is assumed to be via glycogen. Quantitations in all four methods depend on assuming the order in which the molecules deposited in glycogen are released.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500295     DOI: 10.1152/ajpendo.2001.281.3.E413

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  8 in total

1.  Effects of a glucokinase activator on hepatic intermediary metabolism: study with 13C-isotopomer-based metabolomics.

Authors:  Itzhak Nissim; Oksana Horyn; Ilana Nissim; Yevgeny Daikhin; Suzanne L Wehrli; Marc Yudkoff; Franz M Matschinsky
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

2.  Renal cortical pyruvate depletion during AKI.

Authors:  Richard A Zager; Ali C M Johnson; Kirsten Becker
Journal:  J Am Soc Nephrol       Date:  2014-01-02       Impact factor: 10.121

3.  Changes in hepatic glycogen cycling during a glucose load in healthy humans.

Authors:  H Stingl; V Chandramouli; W C Schumann; A Brehm; P Nowotny; W Waldhäusl; B R Landau; M Roden
Journal:  Diabetologia       Date:  2005-12-28       Impact factor: 10.122

4.  Direct and indirect effects of amino acids on hepatic glucose metabolism in humans.

Authors:  M Krebs; A Brehm; M Krssak; C Anderwald; E Bernroider; P Nowotny; E Roth; V Chandramouli; B R Landau; W Waldhäusl; M Roden
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

5.  Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.

Authors:  Theodore Latsis; Birgitte Andersen; Loranne Agius
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

Review 6.  Tracking the carbons supplying gluconeogenesis.

Authors:  Ankit M Shah; Fredric E Wondisford
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

7.  Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes.

Authors:  Michaela Kacerovsky; John Jones; Albrecht I Schmid; Cristina Barosa; Angelika Lettner; Gertrud Kacerovsky-Bielesz; Julia Szendroedi; Marek Chmelik; Peter Nowotny; Visvanathan Chandramouli; Michael Wolzt; Michael Roden
Journal:  Diabetes       Date:  2011-05-11       Impact factor: 9.461

8.  Disposition of a Glucose Load into Hepatic Glycogen by Direct and Indirect Pathways in Juvenile Seabass and Seabream.

Authors:  João Rito; Ivan Viegas; Miguel A Pardal; Isidoro Metón; Isabel V Baanante; John G Jones
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.